NCD prevention in India: setting an example for low-cost interventions in emerging and developing economies
November 14, 2011
By Ashok Malik
Earlier this month, India Health Progress (IHP), an advocacy and research organisation, and PFCD co-hosted a roundtable discussion in New Delhi on the “Growing Social and Economic Burden of Non-Communicable Diseases in India”.
October 19, 2011
By Ashok Malik
How do you measure the toll of premature deaths from non-communicable diseases (NCDs) like lung diseases, diabetes, cardiovascular disease and cancer?
There are alarmists who believe NCDs, with a middle-class demographic profile, will crowd out CDs, which have an underprivileged demographic profile. I recently participated in a conference on tuberculosis (TB) in Bangalore, India and realized how specious such reasoning is. NCDs and CDs don’t exist in watertight compartments, permanently sequestered from each other. The interaction and the osmosis are far greater than we imagine.
This September an event will take place in New York that could define the world’s agenda for the coming decade. I refer, of course, to the high-level meeting of the United Nations General Assembly on the prevention and control of non-communicable diseases. It takes place in New York on September 19 and 20.
Just how much of a threat are non-communicable diseases (NCDs) to emerging economies? Take India, a country where economic change is both endangered by chronic diseases and is also, paradoxically, spurring these.